Results 61 to 70 of about 1,863 (181)

Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid‐induced myopathy

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 2, Page 340-349, February 2025.
Abstract Background Patients with autoimmune blistering diseases (AIBDs) are often exposed to chronic glucocorticoid (GC) treatment with many side effects. Glucocorticoid‐induced myopathy (GIM) is a well‐established side effect, which particularly affects the proximal muscles.
A. He   +19 more
wiley   +1 more source

Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database

open access: yesDermatologic Therapy, Volume 2025, Issue 1, 2025.
Background: Immune checkpoint inhibitors (ICIs) revolutionize cancer therapy but frequently cause immune‐related adverse events (irAEs), with autoimmune skin diseases (ASDs) being significant toxicities requiring careful management. Objective: This study explores the association between ICIs and 10 common ASDs using the FAERS database, aiming to ...
Zi-Yue Dong   +3 more
wiley   +1 more source

Epidemiology of Pemphigus

open access: yesJID Innovations, 2021
Pemphigus is an epidemiologically heterogeneous group of autoimmune bullous diseases comprising pemphigus vulgaris (PV), pemphigus foliaceus, paraneoplastic pemphigus, IgA pemphigus, and pemphigus herpetiformis.
Khalaf Kridin, Enno Schmidt
doaj  

Data on HLA class I/II profile in Brazilian pemphigus patients

open access: yesData in Brief, 2016
Pemphigus are blistering autoimmune diseases related with genetic and environmental factors. Here we describe HLA genotyping in pemphigus patients. First, we review the HLA class I/II data on pemphigus reported in Brazilian samples and then present the ...
Maria José Franco Brochado   +4 more
doaj  

CTLA4 CT60 gene polymorphism is not associated with differential susceptibility to pemphigus foliaceus

open access: yesGenetics and Molecular Biology, 2010
Pemphigus foliaceus is an organ-specific autoimmune disease characterized by autoantibodies against the extracellular region of desmoglein 1, a protein that mediates intercellular adhesion in desmosomes.
Márcia Regina Pincerati   +2 more
doaj  

Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus

open access: yesScientific Reports, 2017
Pemphigus is an autoimmune blistering skin disease caused primarily by autoantibodies against desmoglein (Dsg)1 and 3. Here, we characterized the mechanisms engaged by pemphigus IgG from patients with different clinical phenotypes and autoantibody ...
Elias Walter   +10 more
doaj   +1 more source

Tumour necrosis factor-α polymorphism as one of the complex inherited factors in pemphigus

open access: yesMediators of Inflammation, 2003
The aim of our study was to analyse a significance of tumour necrosis factor (TNF)-α promoter gene polymorphisms in relation to the HLA-DR locus in genetic predisposition to pemphigus.
Jolanta Dorota Torzecka   +6 more
doaj   +1 more source

Ultrastructural skin alterations of healthy subjects with anti-desmoglein 1 antibodies in endemic areas to pemphigus foliaceus: A case series

open access: yesJournal of Translational Autoimmunity, 2023
Background: Endemic pemphigus foliaceus and endemic pemphigus vulgaris are autoimmune dermatologic disorders endemic to the Peruvian Amazon. Objective: To determine the ultrastructural skin alterations of three healthy subjects with anti DSG-1 antibodies
Willy Ramos   +10 more
doaj  

Monoterapia rytuksymabem w pęcherzycy liściastej

open access: yesPrzegląd Dermatologiczny, 2011
Introduction. Rituximab is a chimeric human-mouse monoclonal antibody,which binds to the CD20 antigen on B and pre-B lymphocytesand causes depletion of CD20+ cells in the mechanism of complement-dependent and independent cytolysis, antibody-dependent ...
Małgorzata Olszewska   +4 more
doaj  

Home - About - Disclaimer - Privacy